MedPath

Comparison of GW433908 and Nelfinavir in HIV Patients Who Have Not Had Antiretroviral Therapy

Phase 3
Conditions
HIV Infections
Registration Number
NCT00008554
Lead Sponsor
Glaxo Wellcome
Brief Summary

The purpose of this study is to compare GW433908 and nelfinavir when each is given with abacavir and lamivudine to HIV patients who have not taken antiretroviral drugs.

Detailed Description

Patients are randomized in a 2:1 scheme to 1 of 2 treatment groups. Group 1 receives GW433908 plus abacavir (ABC) plus lamivudine (3TC); Group 2 receives nelfinavir (NFV) plus ABC plus 3TC. Patients undergo safety and efficacy assessments at the Screening Visit, Day 1 (Entry), and Weeks 1, 2, 4, 8, 12, 16, 20, 24, and every 8 weeks thereafter. A follow-up visit is performed 4 weeks after the permanent discontinuation of study drug. Detailed assessments for the development of lipodystrophy/fat redistribution occur at Day 1, Week 24, Week 48, and every 16 weeks thereafter. Patients have examinations and laboratory tests performed at visits.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
210
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (23)

Ocean View Internal Medicine

🇺🇸

Long Beach, California, United States

Saint Michael's Med Ctr

🇺🇸

Newark, New Jersey, United States

Hillsborough County Health Dept

🇺🇸

Tampa, Florida, United States

Howard Grossman

🇺🇸

New York, New York, United States

Bronx Municipal Hosp Ctr/Jacobi Med Ctr

🇺🇸

Bronx, New York, United States

Brookdale Univ Hosp and Med Ctr

🇺🇸

Brooklyn, New York, United States

Florida ID Group

🇺🇸

Orlando, Florida, United States

Clinical Pharmacology Services

🇺🇸

Tampa, Florida, United States

Univ of Rochester Med Ctr

🇺🇸

Rochester, New York, United States

East Bay Clinical Trial Ctr

🇺🇸

Concord, California, United States

Veterans Affairs Med Ctr of North Chicago

🇺🇸

Chicago, Illinois, United States

Univ of Texas Med Branch

🇺🇸

Galveston, Texas, United States

Univ of Kansas Med Ctr

🇺🇸

Kansas City, Kansas, United States

Gervais Frechette

🇺🇸

New York, New York, United States

Addiction Research and Treatment Corp

🇺🇸

Brooklyn, New York, United States

Mount Sinai School of Medicine

🇺🇸

New York, New York, United States

SMO-USA Inc

🇺🇸

Charlotte, North Carolina, United States

Advanced Clinical Trials Inc

🇺🇸

Eugene, Oregon, United States

Thomas Jefferson Univ

🇺🇸

Philadelphia, Pennsylvania, United States

Southwest Texas Methodist Hosp

🇺🇸

San Antonio, Texas, United States

MacGregor Med Association

🇺🇸

Houston, Texas, United States

Walter Gaman

🇺🇸

Irving, Texas, United States

UMDNJ - New Jersey Med School

🇺🇸

Newark, New Jersey, United States

© Copyright 2025. All Rights Reserved by MedPath